© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#genomic testing
Test May Predict Tumors Most Likely to Respond to Radiation, Chemotherapy
TRACKing Rare Mutations
illustration DNA helix
Meeting Your Match
Colon cancer

Black Colorectal Cancer Patients May Have Fewer Treatment Options

Genomic profiling showed patients with African ancestry had fewer actionable mutations and were less likely to qualify for immunotherapy.

The Negative Impact of Continued Exclusion of Racial Groups from Research on Cancer Genomics

Including people in Africa and with African ancestry in studies on inherited genetics to address disparities in prostate cancer outcomes.

Blood Test Identifies Acute Myeloid Leukemia Patients at Greater Risk for Relapse After Bone Marrow Transplant

A small group of adults in remission had persisting mutations that predicted their risk of death from having the cancer return.

Precision Nutrition for Cancer Treatment

In the near future, it may be possible to design specific diets tailored to individual genomic profiles to starve tumors.

Genomic Test May Predict Long-term Prognosis of Early Breast Cancer

Assay can also help identify patients who may benefit from ovarian suppression therapy.

Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s Syndrome

Study clarifies molecular pathways by which CLL transform into a more aggressive type of lymphoma.

FDA Approves Second KRAS Drug for Lung Cancer

Krazati led to tumor shrinkage in 43% of previously treated NSCLC patients with KRAS G12C mutations.

Black Women With Breast Cancer May Have Worse Outcomes Despite Similar Genetic Recurrence Scores

Genomic testing is an important tool to guide treatment decisions among women with early-stage breast cancer.

Is a Genomic Test Better at Finding Aggressive Prostate Cancer?

It’s important to know how aggressive a patient’s cancer is so that their treatment can be tailored.

Genetic Tests Create Treatment Opportunities and Confusion for Breast Cancer Patients

The clinical significance of many of the inherited mutations that can now be identified remains unclear.

“Everything You Know About Survival Analysis in Cancer Is Wrong”

A new approach to prognosis looks to patients’ genomes for clues about how their cancer will behave.

Molecular Profiling of Pediatric Tumors Can Enhance Clinical Care

Genomic tumor profiling in pediatric patients can clarify diagnosis and treatment, a recent study found.

Immunotherapy Shows 100% Response Rate for Selected Rectal Cancer Patients

In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair.

Genomic Profiling May Expand Treatment Options for Children Experiencing Cancer Relapse

Pediatric patients were matched to therapies targeting specific mutations found in their cancers.

Genetic Risk Score Could Identify Men With High-Risk Prostate Cancer

Study confirms that Black men are at higher risk for prostate cancer disease progression and death.

Top 10 Cancer Science Highlights of 2021

A look back at some of the most important science and treatment news Cancer Health covered this year.
Advertisement
Ask Cancer Health
Cancer Health Stories

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.